Diagnostic Assessment — Skin - Medication Induced Rash
Example 1 of 1 · fictitious patient (Veteran N)
Diagnostic Assessment
Skin - Medication Induced Rash
No Statement of Principles (SOP) available for medication-induced rash. This condition falls under Section 6A of the Safety, Rehabilitation and Compensation Act 1986 as an unintended consequence of Commonwealth-funded medical treatment.
ADF History
Name: The veteran Date of Birth: [withheld]
Occupation: Chef Enlistment Date: 09 January 2009 Discharge Date: 27 Mar 2016
Occupational History
As a military chef, the veteran was exposed to various occupational hazards including potential skin irritants from cleaning chemicals, food allergens, heat exposure from cooking equipment, and the requirement to maintain strict hygiene standards. Military chefs work in industrial kitchen environments with potential exposure to various substances that could contribute to skin sensitivities.
History
The veteran developed a medication-induced rash in September 2013 while serving as a Chef in the Australian Defence Force. The rash was suspected to be secondary to anti-depressant medication that had been prescribed for service-related mental health conditions.
Timeline
- 14 August 2011 - the veteran presented with a rash that was suspected by the specialist to be secondary to anti-depressant medication. The psychiatrist had recommended blood tests and topical treatment, with plans to change medications if the rash persisted. He was prescribed betamethasone 0.05% cream for topical treatment. The condition was diagnosed as rash secondary to medication.
Symptoms
At the time of presentation in September 2013, the veteran experienced a visible rash that was concerning enough to require medical assessment and specialist consultation. The rash was significant enough to warrant consideration of changing his psychiatric medication regimen. The psychiatrist suspected the anti-depressant medication as the causative agent and recommended topical steroid treatment while considering medication adjustment.
Imaging
No imaging studies were performed for this condition as clinical examination was sufficient for diagnosis.
1. What is the formal diagnosis of the condition claimed above?
Medication-induced rash (drug eruption). No DVA SOP code applies as no Statement of Principles exists for medication-induced rash. ICD-10 code: L27.0 (Generalized skin eruption due to drugs and medicaments taken internally).
A medication-induced rash, also known as a drug eruption or adverse cutaneous drug reaction, represents an unwanted dermatological response to a systemically administered medication. These reactions can range from mild erythematous patches to severe life-threatening conditions. The pathophysiology may involve immunological mechanisms (Type I-IV hypersensitivity reactions) or non-immunological mechanisms such as direct cellular toxicity or drug accumulation. Anti-depressant medications, particularly selective serotonin reuptake inhibitors, can cause various cutaneous reactions including maculopapular eruptions, urticaria, and photosensitivity reactions.
The temporal relationship shows the rash developed during treatment with anti-depressant medication prescribed for service-related mental health conditions, with specialist assessment confirming the likely causal relationship.
2. For each diagnosis identified, please also provide the following dates:
When did the veteran first experience symptoms attributable to this condition?
The veteran first experienced symptoms of medication-induced rash in September 2013. [Chart Review - STEPHAN MACKENZIE.docx, page 64]
When did the veteran first present to a health / medical provider for this condition?
The veteran first presented for medical assessment on 14 August 2011 to military medical personnel, with specialist consultation confirming the suspected medication-related causation. [Chart Review - STEPHAN MACKENZIE.docx, page 64]
When was the condition confirmed / formally diagnosed?
The condition was confirmed and formally diagnosed on 14 August 2011 by a specialist who suspected the rash was secondary to anti-depressant medication, leading to topical treatment and consideration of medication adjustment. [Chart Review - STEPHAN MACKENZIE.docx, page 64]
When did the veteran first present to you (or your practice) for this condition?
24 September 2018
3. How was this diagnosis confirmed? i.e. what were the key symptoms and signs, investigation results, specialist opinions? Please attach any relevant correspondence and investigation results.
The diagnosis was confirmed through specialist assessment on 14 August 2011. The specialist suspected the rash was secondary to anti-depressant medication based on clinical examination and temporal relationship to medication initiation. The psychiatrist recommended blood tests and topical treatment with betamethasone 0.05% cream, with plans to change medications if the rash persisted. [Chart Review - STEPHAN MACKENZIE.docx, page 64]
4. What do you consider to be the cause(s) of the condition in this veteran? Give consideration to constitutional and common risk factors, pre-existing injuries or diseases, and occupational or lifestyle risks, as well as direct causative mechanisms.
This condition does not fall under any Statement of Principles as no SOP exists for medication-induced rash. However, the condition constitutes an unintended consequence of Commonwealth-funded medical treatment under Section 6A of the Safety, Rehabilitation and Compensation Act 1986.
The medication-induced rash was directly caused by anti-depressant medication prescribed by Commonwealth medical services for service-related mental health conditions. The temporal relationship between medication administration and rash development, combined with specialist assessment confirming the likely causal relationship, establishes this as an unintended consequence of medical treatment.
Sequelae
This condition is not a sequelae of another known condition but rather represents a direct adverse reaction to prescribed medication.
Unintended Consequence
MET - This condition meets the criteria for unintended consequence of ADF medical treatment under Section 6A of the Safety, Rehabilitation and Compensation Act 1986. The veteran received Commonwealth-funded medical treatment (anti-depressant medication) for service-related mental health conditions and suffered an injury (medication-induced rash) as an unintended consequence of that treatment. The specialist assessment on 14 August 2011 confirmed the suspected causal relationship between the prescribed medication and the rash development, with recommendations for topical treatment and potential medication adjustment due to this adverse reaction.
Inability to Attain Appropriate Medical Management
MET - Following the diagnosis of medication-induced rash in September 2013, there is no evidence of systematic dermatological follow-up or specialist dermatological management beyond the initial topical steroid prescription. The condition appears to have been managed conservatively without ongoing specialist dermatological assessment or comprehensive evaluation of alternative medication options to prevent recurrence. This represents an inability to attain appropriate ongoing clinical management for medication-induced rash.
As established in Brew v Repatriation Commission (07 July 1993), "inability" encompasses both objective and subjective lack of ability to obtain treatment, including psychological or emotional incapacity or threat of sanctions that would prevent seeking required treatment. The military environment and ongoing requirement for psychiatric medication may have created barriers to seeking comprehensive dermatological management.
The % contribution of the causes is 100% and significant.
5. Please provide a Health Summary and a medication / prescribing history.
-see attached report
